Pfizer Inc.
Vito Lopez Moves To Take Pfizer's Brooklyn Site By Eminent Domain [UPDATED]
Earlier this month, in the brief few-day period when only one governor was embroiled in a sex scandal, Brooklyn Assemblyman Vito Lopez introduced a bill to use eminent domain to take pharmaceutical giant Pfizer’s approximately 15-acre manufacturing plant site in East Williamsburg and turn it into affordable housing (he's talked about this previously).
With the plant slated to close later this year, Pfizer had put out a search in January for developers to buy the land and build a mixed-use, mixed-income development out of the site.
Though the company has yet to report any progress along that front, and even that concept—of a mixed-income complex—angered Mr. Lopez, the Assembly housing committee chairman, who previously has expressed revulsion at the notion that the company would proceed down a path that would bring it any significant financial gain.
The bill, introduced March 13 with 20 other legislators signing on, instructs the Division of Housing and Community Renewal to take the property with eminent domain. In the bill’s justification listed on the Assembly’s Web site, Mr. Lopez said he was taking action on Pfizer because it failed to donate its land, as it has done in other instances. "Though Pfizer has shown concern for other communities coping with job loss and housing needs, it appears the global company has little interest in returning the land in question to the State of New York," the justification reads. read more »
Pfizer Offering Williamsburg Plant Site for Affordable Housing—So, Why’s a State Assemblyman Trying to Seize It?
Pharmaceutical giant Pfizer is opting to leave the Brooklyn community that gave it its start 159 years ago with something of a mixed-income goodbye kiss, as its seeks to turn its giant 15-acre southeast Williamsburg site into a new development marked by affordable housing. read more »
Pfizer to Leave Brooklyn
Pharma Goes to the Bronx

The new 28,000 square-foot Pfizer Plant Research Laboratory, funded partially by you-know-who and designed by Polshek Partnership, opens this week at the New York Botanical Garden. It will be open to the public until Sunday before being closed for students and scientists to study molecular systems and plant genomics. Get your wiggly worms here. read more »
-Matthew SchuermanBuying the Caucus
It would have been an expensive affair, too, but for the generosity of AstraZeneca, GlaxoSmithKline, PhRMA, and Pfizer.
Also on the list of sponsors: booze and nuclear power.
So decent of those public-minded corporations to recognize how often state legislators are deprived of free food and alchohol.
UPDATE: That didn't take long. The Web site, and list of sponsors, is down. Fortunately, an archived, similar list of the 2005 event sponsors is here.













